4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0000899243-21-026769
Director bought 157,895 shares at $19.00 ($3,000,005)
- Director acquired 8,455,912 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD Director | 2021-06-28 | Conversion | +6,515,869 | 6,799,115 | I | ||
| Bolzon Bradley J PhD Director | 2021-06-28 | Conversion | +1,940,043 | 1,940,043 | I | ||
| Bolzon Bradley J PhD Director | 2021-06-28 | Purchase | +157,895 | $19.00 | $3,000,005 | 2,097,938 | I |
| Derivatives | |||||||
| Bolzon Bradley J PhD Director | 2021-06-28 | Conversion · Series A convertible preferred stock | −20,004,280 | 0 | I | ||
| Bolzon Bradley J PhD Director | 2021-06-28 | Conversion · Series B convertible preferred stock | −3,000,000 | 0 | I | ||
| Bolzon Bradley J PhD Director | 2021-06-28 | Conversion · Series B convertible preferred stock | −4,150,000 | 0 | I | ||
| Bolzon Bradley J PhD Director | 2021-06-28 | Conversion · Series C convertible preferred stock | −2,699,328 | 0 | I | ||
| Open-market purchases · 157,895 sh · avg $19.00 · $3,000,005 | |||||||
Loading xslF345X03/doc4.xml…